Because of the low prevalence, not much is known about the natural history of patients with congenital disorders of glycosylation (CDG). Knowledge about the natural disease course is of major importance to inform patients and parents and to prepare intervention studies. The CDG Biobank contains biomaterial (DNA, plasma (EDTA and heparin) and urine) and specific data from the medical file of participating patients.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Financial regulation for sub-biobanks15 September 2020
Sub-biobanks are not required to pay up-front for the processing and storage of biomaterials. The effectiveness of this pre-financing agreement however is dependent on adherence to the demands regarding delivery and processing according to the Radboud Biobank standard operating procedures.read more